Literature DB >> 6331147

Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients.

D L Sprecher, E J Schaefer, K M Kent, R E Gregg, L A Zech, J M Hoeg, B McManus, W C Roberts, H B Brewer.   

Abstract

Familial hypercholesterolemia (FH) is characterized by an autosomal codominant inheritance, an abnormality in low-density lipoprotein (LDL) receptor function, elevated plasma cholesterol levels and premature atherosclerosis. Sixteen patients with homozygous FH were studied to correlate the extent of their atherosclerotic disease with their lipid levels and receptor function. The age range at initial presentation was 3 to 38 years (mean 12), and at the last examination, 6 to 43 years (mean 20). The mean pretreatment total plasma cholesterol concentration for all patients was 729 +/- 58 mg/dl (+/- standard error of the mean), and the mean LDL cholesterol level was 672 +/- 58 mg/dl (normal 60 to 176). High-density lipoprotein cholesterol was 28 +/- 3 mg/dl (normal 30 to 74). In the 7 patients with FH who had symptoms of myocardial ischemia (Group I), the mean pretreatment LDL cholesterol value (817 +/- 62 mg/dl) was higher than that of the 9 asymptomatic patients (Group II) (560 +/- 74 mg/dl). In Group I, 5 of 7 patients had left or right coronary ostial narrowing and 3 had significant left ventricular outflow obstruction. Most coronary arterial narrowing occurred in the right coronary and left anterior descending arteries and the least amount in the left circumflex coronary artery. A femoral bruit was the physical finding that correlated best with the Group I population; brother:sister pairs revealed a milder clinical course for the female. Seven of the 16 patients have survived into their third decade without symptoms. Comparison of these persons with those in whom angina developed reveals a marked heterogeneity in their clinical course, which appears to be associated with receptor negative/defective status.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331147     DOI: 10.1016/0002-9149(84)90298-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  41 in total

1.  Relationships of mitral annular calcification to cardiovascular risk factors: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Somsupha Kanjanauthai; Khurram Nasir; Ronit Katz; Juan J Rivera; Junichiro Takasu; Roger S Blumenthal; John Eng; Matthew J Budoff
Journal:  Atherosclerosis       Date:  2010-09-16       Impact factor: 5.162

Review 2.  Calcific aortic stenosis: from bench to the bedside--emerging clinical and cellular concepts.

Authors:  Nalini M Rajamannan; Bernard Gersh; Robert O Bonow
Journal:  Heart       Date:  2003-07       Impact factor: 5.994

Review 3.  Fatty acid composition of the diet: impact on serum lipids and atherosclerosis.

Authors:  N Zöllner; F Tatò
Journal:  Clin Investig       Date:  1992-11

4.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

5.  A cholesterol-lowering gene maps to chromosome 13q.

Authors:  H Knoblauch; B Müller-Myhsok; A Busjahn; L Ben Avi; S Bähring; H Baron; S C Heath; R Uhlmann; H D Faulhaber; S Shpitzen; A Aydin; A Reshef; M Rosenthal; O Eliav; A Mühl; A Lowe; D Schurr; D Harats; E Jeschke; Y Friedlander; H Schuster; F C Luft; E Leitersdorf
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

Review 6.  Calcific aortic valve disease: not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update.

Authors:  Nalini M Rajamannan; Frank J Evans; Elena Aikawa; K Jane Grande-Allen; Linda L Demer; Donald D Heistad; Craig A Simmons; Kristyn S Masters; Patrick Mathieu; Kevin D O'Brien; Frederick J Schoen; Dwight A Towler; Ajit P Yoganathan; Catherine M Otto
Journal:  Circulation       Date:  2011-10-18       Impact factor: 29.690

Review 7.  Diseases of Wnt signaling.

Authors:  Mark L Johnson; Nalini Rajamannan
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

8.  Is it time for medical therapy for aortic valve disease?

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2004-11

9.  Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease.

Authors:  B G Schreurs; C A Smith-Bell; S K Lemieux
Journal:  Neuroscience       Date:  2013-09-14       Impact factor: 3.590

10.  Lipid deposition in human tendon xanthoma.

Authors:  H S Kruth
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.